BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29667068)

  • 21. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
    Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of care in elderly glioblastoma patients.
    Iwamoto FM; Reiner AS; Panageas KS; Elkin EB; Abrey LE
    Ann Neurol; 2008 Dec; 64(6):628-34. PubMed ID: 19107984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme.
    Li L; Quang TS; Gracely EJ; Kim JH; Emrich JG; Yaeger TE; Jenrette JM; Cohen SC; Black P; Brady LW
    J Neurosurg; 2010 Aug; 113(2):192-8. PubMed ID: 20345222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients.
    Arvold ND; Tanguturi SK; Aizer AA; Wen PY; Reardon DA; Lee EQ; Nayak L; Christianson LW; Horvath MC; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Alexander BM
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):384-9. PubMed ID: 25841623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of care and predictors of adjuvant therapies in elderly patients with glioblastoma: An analysis of the National Cancer Data Base.
    Amsbaugh MJ; Yusuf MB; Gaskins J; Burton EC; Woo SY
    Cancer; 2017 Sep; 123(17):3277-3284. PubMed ID: 28452053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newly diagnosed glioblastoma: adverse socioeconomic factors correlate with delay in radiotherapy initiation and worse overall survival.
    Pollom EL; Fujimoto DK; Han SS; Harris JP; Tharin SA; Soltys SG
    J Radiat Res; 2018 Mar; 59(suppl_1):i11-i18. PubMed ID: 29432548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of survival between cerebellar and supratentorial glioblastoma patients: surveillance, epidemiology, and end results (SEER) analysis.
    Jeswani S; Nuño M; Folkerts V; Mukherjee D; Black KL; Patil CG
    Neurosurgery; 2013 Aug; 73(2):240-6; discussion 246; quiz 246. PubMed ID: 23615082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gross-total resection outcomes in an elderly population with glioblastoma: a SEER-based analysis.
    Noorbakhsh A; Tang JA; Marcus LP; McCutcheon B; Gonda DD; Schallhorn CS; Talamini MA; Chang DC; Carter BS; Chen CC
    J Neurosurg; 2014 Jan; 120(1):31-9. PubMed ID: 24205904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme.
    Fuller CD; Choi M; Forthuber B; Wang SJ; Rajagiriyil N; Salter BJ; Fuss M
    Radiat Oncol; 2007 Jul; 2():26. PubMed ID: 17629934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation response and survival time in patients with glioblastoma multiforme.
    Barker FG; Prados MD; Chang SM; Gutin PH; Lamborn KR; Larson DA; Malec MK; McDermott MW; Sneed PK; Wara WM; Wilson CB
    J Neurosurg; 1996 Mar; 84(3):442-8. PubMed ID: 8609556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between giant cell glioblastoma and glioblastoma multiforme in the United States: A retrospective cohort study.
    Bin Abdulrahman AK; Bin Abdulrahman KA; Bukhari YR; Faqihi AM; Ruiz JG
    Brain Behav; 2019 Oct; 9(10):e01402. PubMed ID: 31464386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients.
    Zinn PO; Colen RR; Kasper EM; Burkhardt JK
    Int J Oncol; 2013 Mar; 42(3):929-34. PubMed ID: 23338774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.
    Zhu P; Du XL; Lu G; Zhu JJ
    Oncotarget; 2017 Jul; 8(27):44015-44031. PubMed ID: 28467795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme.
    Aneja S; Khullar D; Yu JB
    J Neurooncol; 2013 May; 112(3):393-401. PubMed ID: 23412775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
    Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
    J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: a population-based analysis.
    Johnson DR; Leeper HE; Uhm JH
    Cancer; 2013 Oct; 119(19):3489-95. PubMed ID: 23868553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy of malignant gliomas: results from conventional treatment methods and the prospects of advanced techniques.
    Rubino G; Sacco P; Cerase A; Volterrani L; Sebaste L; Pepi F; Pirtoli L
    Radiol Med; 2004; 107(1-2):128-35. PubMed ID: 15031704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival for elderly married glioblastoma patients : Better treatment delivery, less toxicity, and fewer disease complications.
    Putz F; Putz T; Goerig N; Knippen S; Gryc T; Eyüpoglu I; Rössler K; Semrau S; Lettmaier S; Fietkau R
    Strahlenther Onkol; 2016 Nov; 192(11):797-805. PubMed ID: 27628965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.